Building Clinical Trials Capacity for Tuberculosis Drugs in High-Burden Countries

Neil Schluger; Unni Karunakara; Christian Lienhardt; Thomas Nyirenda; Richard Chaisson

doi:10.1371/journal.pmed.0040302

Loading metrics

Open Access

Policy Forum articles provide a platform for health policy makers from around the world to discuss the challenges and opportunities in improving health care to their constituencies.

See all article types »

Building Clinical Trials Capacity for Tuberculosis Drugs in High-Burden Countries

Neil Schluger,
Unni Karunakara ,

*To whom correspondence should be addressed. E-mail: unni.karunakara@msf.org
⨯
Christian Lienhardt,
Thomas Nyirenda,
Richard Chaisson

Building Clinical Trials Capacity for Tuberculosis Drugs in High-Burden Countries

Neil Schluger,
Unni Karunakara,
Christian Lienhardt,
Thomas Nyirenda,
Richard Chaisson

Published: November 6, 2007
https://doi.org/10.1371/journal.pmed.0040302

About the Authors

Neil Schluger
Unni Karunakara: *To whom correspondence should be addressed. E-mail: unni.karunakara@msf.org
Christian Lienhardt
Thomas Nyirenda
Richard Chaisson

Competing Interests

NS has received research grants from the United States National Institutes of Health and Centers for Disease Control and Prevention. CL has received funds from the European Commission and United States Agency for International Development. TN is Networking Manager of the European and Developing Countries Clinical Trials Partnership. RC has received research grants from the National Institutes of Health, Centers for Disease Control and Prevention, Food and Drug Administration, and Bill & Melinda Gates Foundation; research material donations and consulting fees from Bayer; and memberships on the World Health Organization's tuberculosis advisory board and American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Panel on TB Treatment.

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Tuberculosis
Is the Subject Area "Tuberculosis" applicable to this article?

Thanks for your feedback.
Clinical trials
Is the Subject Area "Clinical trials" applicable to this article?

Thanks for your feedback.
Drug research and development
Is the Subject Area "Drug research and development" applicable to this article?

Thanks for your feedback.
Extensively drug-resistant tuberculosis
Is the Subject Area "Extensively drug-resistant tuberculosis" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Consortia
Is the Subject Area "Consortia" applicable to this article?

Thanks for your feedback.
Multi-drug-resistant tuberculosis
Is the Subject Area "Multi-drug-resistant tuberculosis" applicable to this article?

Thanks for your feedback.
Tuberculosis drug discovery
Is the Subject Area "Tuberculosis drug discovery" applicable to this article?

Thanks for your feedback.